|
1）Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995; 40: 1561-8
|
|
|
|
2）Kamisawa T, Takuma K, Egawa N, et al. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010; 7: 401-9
|
|
|
|
|
|
3）Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 vs type 2 autoimmune pancreatitis. Gastroenterology. 2010; 139: 140-8
|
|
|
|
|
|
4）Kamisawa T, Chari ST, Lerch MM, et al. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut. 2013; 62: 1373-80
|
|
|
|
|
|
5）Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011; 40: 352-8
|
|
|
|
|
|
6）Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012; 64: 3061-7
|
|
|
|
|
|
7）Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012; 25: 1181-92
|
|
|
|
|
|
8）Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010; 45: 471-7
|
|
|
|
|
9）Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008; 134: 706-15
|
|
|
|
|
|
10）Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013; 62: 1607-15
|
|
|
|
|
|
11）Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2008; 6: 364-6
|
|
|
|
|
|
12）Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the treatment of IgG4-related disease: lesions from 10 consecutive patients. Medicine. 2012; 91: 57-66
|
|
|
|
|
|
13）Kamisawa T, Kim MH, Liao WC, et al. Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria. Pancreas. 2011; 40: 200-5
|
|
|
|
|
|
14）Kamisawa T, Chari ST, Giday SA, et al. Clinical proifile of autoimmune pancreatitis and its histological subtypes. An international multicenter survey. Pancreas. 2011; 40: 809-14
|
|
|
|
|
|
15）Hart PA, Kamisawa T, Brugger WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre international analysis. Gut. 2013; 62: 1771-6
|
|
|
|
|